Updated Jan 11, 2008 at 8:53 EST.
Johnson & Johnson are the creators of Dapoxetine ( Prilogy™ ) a pill which is foreseen to be one of the leading premature ejaculation treatments.
The Johnson & Johnson establishment owns many other companies including ETHICON, INC.
ETHICON, INC is celebrating their recent success with their Fibrin Sealant ( Human).
This fibrin sealant is designed to be an adjunct to hemostatis, to be used during surgery.
On January 10th 2008 the Food and Drug Administration granted an expanded indication for the drug.
This is one of many successes for the Johnson & Johnson cooperation.
Their work developing effective treatments for premature ejaculation is only a small fraction of the accomplishments the company can take credit for.
With ownership of pharmaceutical companies all over the world, Johnson & Johnson is developing a variety of treatments for all kinds of conditions.
Written by the PEhomepage.com Editorial Team.
Back to Articles 
Latest News Archive 
E-mail a Friend
